Do All Heart Attack Survivors Need Long-Term Beta Blocker Meds?
THURSDAY, May 4, 2023 (HealthDay News) — It’s standard for heart attack survivors to take beta blocker medications for years afterward, but a new study suggests that may be unnecessary for people who’ve had a milder heart attack. Researchers found th…
Learn MoreOdds of Miscarriage Reduced in Association With Healthy Diet
THURSDAY, May 4, 2023 (HealthDay News) — For healthy women of reproductive age, the odds of miscarriage are reduced in association with a healthy diet, high in fruits and vegetables, according to a review published online April 13 in Fertility and St…
Learn MoreEat, Sleep, Console Approach Beneficial for Neonatal Opioid Withdrawal
THURSDAY, May 4, 2023 (HealthDay News) — For infants with neonatal opioid withdrawal syndrome, use of the Eat, Sleep, Console care approach reduces the number of days until medical readiness for discharge, according to a study published online April …
Learn MoreTemporary Interruption of Endocrine Therapy for Breast Cancer Safe
THURSDAY, May 4, 2023 (HealthDay News) — Among select women with previous hormone receptor-positive early breast cancer, there is no increase in the short-term risk for breast cancer events with temporary interruption of endocrine therapy to attempt …
Learn MoreKids With Nonverbal Autism May Still Understand Much Spoken Language
THURSDAY, May 4, 2023 (HealthDay News) — About a third of children with autism aren’t able to speak — but that doesn’t mean they’re unable to listen and comprehend, a new study reports.About 1 in 4 kids and teens who have autism and are minimally ve…
Learn MoreFTD-TPI Plus Bevacizumab Increases Survival in Refractory Advanced CRC
THURSDAY, May 4, 2023 (HealthDay News) — Treatment with trifluridine-tipiracil (FTD-TPI) plus bevacizumab yields longer overall survival than FTD-TPI alone among patients with refractory metastatic colorectal cancer, according to a study published in…
Learn MoreIdiopathic CD4 Lymphocytopenia Linked to Opportunistic Infection, Cancer
THURSDAY, May 4, 2023 (HealthDay News) — Idiopathic CD4 lymphocytopenia (ICL) is associated with increased risk for opportunistic infection and invasive cancer, according to a study published in the May 4 issue of the New England Journal of Medicine….
Learn More